MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
12.39
+0.04 (0.32%)
At close: Sep 18, 2026, 4:00 PM EDT
12.36
-0.03 (-0.24%)
After-hours: Sep 18, 2026, 7:53 PM EDT

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $1.05 billion. The enterprise value is $618.97 million.

Market Cap1.05B
Enterprise Value 618.97M

Important Dates

The next estimated earnings date is Wednesday, November 4, 2026, before market open.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

MLTX has 85.11 million shares outstanding. The number of shares has increased by 9.53% in one year.

Current Share Class 85.11M
Shares Outstanding 85.11M
Shares Change (YoY) +9.53%
Shares Change (QoQ) +3.71%
Owned by Insiders (%) 7.80%
Owned by Institutions (%) 60.42%
Float 55.47M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 3,999.69
PB Ratio 2.41
P/TBV Ratio 2.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.56, with a Debt / Equity ratio of 0.24.

Current Ratio 12.56
Quick Ratio 11.98
Debt / Equity 0.24
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -26.59

Financial Efficiency

Return on equity (ROE) is -67.47% and return on invested capital (ROIC) is -34.81%.

Return on Equity (ROE) -67.47%
Return on Assets (ROA) -32.44%
Return on Invested Capital (ROIC) -34.81%
Return on Capital Employed (ROCE) -50.77%
Weighted Average Cost of Capital (WACC) 9.76%
Revenue Per Employee n/a
Profits Per Employee -$2.03M
Employee Count130
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, MLTX has paid $1.08 million in taxes.

Income Tax 1.08M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -75.79% in the last 52 weeks. The beta is 1.03, so MLTX's price volatility has been similar to the market average.

Beta (5Y) 1.03
52-Week Price Change -75.79%
50-Day Moving Average 16.66
200-Day Moving Average 16.88
Relative Strength Index (RSI) 24.93
Average Volume (20 Days) 1,442,405

Short Selling Information

The latest short interest is 7.14 million, so 8.39% of the outstanding shares have been sold short.

Short Interest 7.14M
Short Previous Month 6.82M
Short % of Shares Out 8.39%
Short % of Float 12.88%
Short Ratio (days to cover) 5.37

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -268.34M
Pretax Income -264.15M
Net Income -263.67M
EBITDA -265.10M
EBIT -268.34M
Earnings Per Share (EPS) -$3.81
Full Income Statement

Balance Sheet

The company has $537.03 million in cash and $101.53 million in debt, with a net cash position of $435.50 million or $5.12 per share.

Cash & Cash Equivalents 537.03M
Total Debt 101.53M
Net Cash 435.50M
Net Cash Per Share $5.12
Equity (Book Value) 428.20M
Book Value Per Share 5.12
Working Capital 524.65M
Full Balance Sheet

Cash Flow

Operating Cash Flow -225.18M
Capital Expenditures n/a
Depreciation & Amortization 3.24M
Net Borrowing 24.47M
Free Cash Flow -225.18M
FCF Per Share -$2.65
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.53%
Shareholder Yield -9.53%
Earnings Yield -25.07%
FCF Yield -21.41%

Analyst Forecast

The average price target for MLTX is $28.54, which is 130.35% higher than the current price. The consensus rating is "Buy".

Price Target $28.54
Price Target Difference 130.35%
Analyst Consensus Buy
Analyst Count 15
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1